Literature DB >> 1650163

Fatal varicella-zoster virus meningoradiculitis without skin involvement.

A N Dueland1, M Devlin, J R Martin, R Mahalingam, R Cohrs, H Manz, I Trombley, D Gilden.   

Abstract

A 77-year-old man with T-cell lymphoma developed an acute fatal meningoradiculitis of cranial nerve roots and cauda equina, pathologically and virologically confirmed to be caused by varicella-zoster virus. This is the first report of fatal varicella-zoster virus-induced neurological disease in the absence of skin lesions. Varicella-zoster virus should be included in the differential diagnosis of acute radiculoneuropathy in the immunocompromised patient, particularly because antiviral treatment for varicella-zoster virus exists.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1650163     DOI: 10.1002/ana.410290520

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  16 in total

1.  Complications of Varicella Zoster Infection of the Central Nervous System.

Authors:  Anusha S Thomas; Jose A Perez
Journal:  Methodist Debakey Cardiovasc J       Date:  2017 Apr-Jun

2.  Varicella zoster meningoradiculitis in Crohn's disease treated with 6-mercaptopurine.

Authors:  Garret Cullen; Douglas Krakower; Jennifer A Mitty; Adam S Cheifetz
Journal:  Inflamm Bowel Dis       Date:  2011-05-25       Impact factor: 5.325

3.  Frequency and abundance of alphaherpesvirus DNA in human thoracic sympathetic ganglia.

Authors:  Maria A Nagel; April Rempel; Jonathon Huntington; Forrest Kim; Alexander Choe; Don Gilden
Journal:  J Virol       Date:  2014-04-30       Impact factor: 5.103

4.  Disseminated VZV infection and asymptomatic VZV vasculopathy after steroid abuse.

Authors:  Maria A Nagel; Daniela Lenggenhager; Teresa White; Nelly Khmeleva; Anna Heintzman; Philip J Boyer; Don Gilden
Journal:  J Clin Virol       Date:  2015-03-18       Impact factor: 3.168

Review 5.  Varicella-zoster virus.

Authors:  A M Arvin
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

6.  Polymerase chain reaction analysis and oligoclonal antibody in the cerebrospinal fluid from 34 patients with varicella-zoster virus infection of the nervous system.

Authors:  S M Gregoire; V van Pesch; S Goffette; A Peeters; C J M Sindic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04-25       Impact factor: 10.154

Review 7.  Pathogenesis and current approaches to control of varicella-zoster virus infections.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 8.  Varicella zoster vaccines and their implications for development of HSV vaccines.

Authors:  Anne A Gershon
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

9.  Detection of latent varicella zoster virus DNA and human gene sequences in human trigeminal ganglia by in situ amplification combined with in situ hybridization.

Authors:  A N Dueland; T Ranneberg-Nilsen; M Degré
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

Review 10.  Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency.

Authors:  Niklaus H Mueller; Donald H Gilden; Randall J Cohrs; Ravi Mahalingam; Maria A Nagel
Journal:  Neurol Clin       Date:  2008-08       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.